Back to Search Start Over

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

Authors :
Stefanie Schulz-Schüpke
Marcus Fischer
Franz-Josef Neumann
Tom Adriaenssens
Adnan Kastrati
Raphaela Lohaus
Anna Lena Lahmann
Sebastian Kufner
Isabell Bernlochner
Yaling Han
Claudius Jacobshagen
Heribert Schunkert
Roisin Colleran
Michael Maeng
Jonathan Michel
Katharina Mayer
Bernhard Zrenner
Jochen Wöhrle
Ralph Tölg
Jurriën M. ten Berg
Roberto Emmer
Karl-Ludwig Laugwitz
Annabelle Wolk
Tanja Morath
Tareq Ibrahim
Robert A. Byrne
Julinda Mehilli
Daniele Giacoppo
Melchior Seyfarth
Yukinori Harada
Source :
Harada, Y, Michel, J, Lohaus, R, Mayer, K, Emmer, R, Lahmann, A L, Colleran, R, Giacoppo, D, Wolk, A, Ten Berg, J M, Neumann, F-J, Han, Y, Adriaenssens, T, Tölg, R, Seyfarth, M, Maeng, M, Zrenner, B, Jacobshagen, C, Wöhrle, J, Kufner, S, Morath, T, Ibrahim, T, Bernlochner, I, Fischer, M, Schunkert, H, Laugwitz, K-L, Mehilli, J, Byrne, R A, Kastrati, A & Schulz-Schüpke, S 2017, ' Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents ', Thrombosis and Haemostasis, vol. 117, no. 10, pp. 1989-1999 . https://doi.org/10.1160/TH17-02-0101
Publication Year :
2017

Abstract

SummaryThe DAPT score is a recently-proposed decision tool for guiding optimal duration of dual antiplatelet therapy (DAPT). It showed modest accuracy in prior derivation and validation cohorts of patients with ≥12 months DAPT. This study was aimed to evaluate the validity of the DAPT score in a cohort of patients with 6 or 12 months DAPT after implantation of predominantly second-generation drug-eluting stents. We analyzed data of patients enrolled in the ISAR-SAFE trial. Patients were classified into low (

Details

Language :
English
Database :
OpenAIRE
Journal :
Harada, Y, Michel, J, Lohaus, R, Mayer, K, Emmer, R, Lahmann, A L, Colleran, R, Giacoppo, D, Wolk, A, Ten Berg, J M, Neumann, F-J, Han, Y, Adriaenssens, T, Tölg, R, Seyfarth, M, Maeng, M, Zrenner, B, Jacobshagen, C, Wöhrle, J, Kufner, S, Morath, T, Ibrahim, T, Bernlochner, I, Fischer, M, Schunkert, H, Laugwitz, K-L, Mehilli, J, Byrne, R A, Kastrati, A & Schulz-Schüpke, S 2017, ' Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents ', Thrombosis and Haemostasis, vol. 117, no. 10, pp. 1989-1999 . https://doi.org/10.1160/TH17-02-0101
Accession number :
edsair.doi.dedup.....065b925791478b9ac29cf1e65b861c2b
Full Text :
https://doi.org/10.1160/TH17-02-0101